Abcede, Maria T.
HRN: 06-36-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/04/2025
01/12/2025
IV
4.5gm
Q6h
Cap Hr; Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes